Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Fourth Quarter and Full Year of 2024

Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) (“Chunghwa” or “the Company”) today reported its un-audited operating results for the fourth quarterof 2024. All figures were prepared in accordance with Taiwan-International Financial Reporting Standards (“T-IFRSs”) on a consolidated basis. (Comparisons throughout the press release, unless otherwise stated, are made with regard to the prior year […]

First Breakthrough Study Highlights Superiority of MatriDerm® in Wound Healing

MatriDerm® by MedSkin Solutions Dr. Suwelack AG Proven to Enhance Cell Activity, Reduce Inflammation, and Deliver Better Wound Healing Outcomes in Research Study MedSkin Solutions Dr. Suwelack AG is pleased to announce the publication of a new study in the International Wound Journal titled 'Comparison of cell-scaffold interactions in a biological and a synthetic wound

Soaring into the Future of Education: Fullerton Drone Lab Takes Center Stage on Viewpoint with Dennis Quaid

The world of education is taking flight, and Viewpoint with Dennis Quaid is set to explore the innovative programs offered by the Fullerton Drone Lab at Fullerton College. This segment, set to air on public television stations nationwide, will showcase how the Drone Lab is preparing students for the high-demand careers of tomorrow. https://mma.prnewswire.com/media/2596981/Fullerton_DroneLogo_Cropped_1.jpg Viewpoint

ION Commodities responds to growing regulatory pressure in energy trading with ION LookOut

ION Commodities, a global leader in energy and commodity management solutions, announces the integration of its Commodity Trading and Risk Management (CTRM) solutions with ION LookOut, an award-winning regulatory reporting and trade surveillance solution. This integration significantly enhances ION CTRM's compliance capabilities, empowering businesses in the energy sector to address growing regulatory demands, manage compliance

Nuvoton Releases 1.7 W 420 nm Indigo Laser Diode

Nuvoton Technology Corporation Japan (hereinafter “NTCJ”) announced on January 15 the launch of its industry-leading (*) indigo semiconductor laser, which emits an optical level of output power of 1.7 W and a wavelength of 420 nm. Details of the new product and alternative light source solutions to mercury lamps will be exhibited at NTCJ's booth

Hivello + AIxblock: Decentralized AI Meets Simplified Node Management

LONDON and AMSTERDAM, Jan. 23, 2025 (GLOBE NEWSWIRE) — Hivello, a platform simplifying decentralized node management for non-technical users, and AIxBlock, a fully decentralized AI development platform redefining the AI compute and dataset marketplace, have announced a strategic partnership. AIxBlock operates at the intersection of artificial intelligence and Web3 technologies, offering a comprehensive development platform

Cancer Research UK, Cytovation and the Norwegian Cancer Society collaborate to advance treatment for rare cancer

Collaboration to take Cytovation's synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinoma Cancer Research UK's Centre for Drug Development to run the trial at sites in UK, and others across Europe The Norwegian Cancer Society to provide co-funding to support the trial LONDON, UK, and BERGEN and OSLO, Norway, 23

Genethon and Eukarys announce a strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies

Press release Genethon and Eukarys announce a strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies Evry, January 23, 2025– Genethon, a pioneer and leader in the research and development of gene therapies for rare diseases, and Eukarys, a biotechnology company developing a disruptive technology that significantly increases biomanufacturing

Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights – REGN

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=124539&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top